Frank Prendergast

Dr Frank Prendergast has a long and distinguished career in the US Healthcare industry with some of his more notable achievements as director for research at Mayo Clinic, member of the Board of Governors for Mayo Clinic and member of Mayo Clinic’s Executive Committee. Dr Prendergast has been a member of the Eli Lilly Company board of directors since 1995, and has served extensively in US National Institutes of Health in various capacities. Dr Prendergast has been non-executive director of Medibio and his vision is to use his extensive network in the US healthcare industry to expand Medibio’s advisory board, and as a platform to assist in the commercialisation of Medibio’s technology for the diagnosis of depression and other mental health disorders.
Bio last updated 16 Feb 2017

Article Timeline

Network Graph

Displaying all related organisations and their related contacts. Hover over a node to display a link to the BNiQ page for that person or organisation.

Positions - Current

PositionCompanyYearCompany's current rankWA staff
Non-Executive Director

Directors Interests

CompanyDateTransaction typeNumber of sharesPrice per shareTransaction valueNature of change
Medibio18 Jun 2018Issued559,556OtherIssue of securities
Source: Morningstar


Non-Executive Director
Year started and most recent title

Share Transactions

$0 Issued
Total value as at the date of the transaction
Source: Morningstar

BNiQ Disclaimer